Drawing for OO

USPTO serial 97409086

OO

Reviewed by CopyMark Law Group

Status 731Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
COWARD, JEFFERY
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 731: Status 731 means the second six-month extension to file a Statement of Use was granted. File a Statement of Use or the next extension before the deadline expires.

Need help with OO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,246*

Plus Government fees of $600

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Yi Zhang

20380 TOWN CENTER LANE, SUITE 128CUPERTINO, CA 95014United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer application software for mobile phones, namely, software for searching genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Downloadable computer software for searching genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Downloadable mobile applications for searching genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell; line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Downloadable software in the nature of a mobile application for searching genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys dataACTIVE—
031Live animals; Live animals, namely, rodent animal, specifically, rats; Live laboratory animalsACTIVE—
042Consulting services in the field of biotechnology; Laboratory research services relating to pharmaceuticals; Medical and scientific research in the field of cancer treatment and diagnosis; Medical laboratory services; Medical research services in the field of cancer; Pharmaceutical drug development services; Providing a members-only website featuring technology which provides members with the ability to search genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Providing a secured-access, members only website featuring technology that gives members the ability to search genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Providing a web site featuring technology that enables users to search genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Providing a website featuring non-downloadable software for searching genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Providing a website featuring on-line nondownloadable software that enables users to search genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Providing a website featuring resources, namely, non-downloadable software for searching genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Providing reagent sample testing and diagnostic services for others for scientific research purposes; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Scientific and technological services, namely, analyzing preclinical oncology efficacy in the field of medical treatment; Scientific laboratory services; Scientific research for medical purposes in the area of cancerous diseases; Technical research in the field of pharmaceutical studiesACTIVE—
044Drug use screening services; Drug use testing services; Drug, alcohol and DNA screening for medical purposes; Medical screening; Medical services, namely, preemployment drug screening; Providing information in the field of cancer prevention, screening, diagnosis and treatmentACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 26, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 25, 2026EX2GSOU EXTENSION 2 GRANTED—
Aug 25, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 22, 2026EXT2SOU EXTENSION 2 FILED—
Jul 22, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 22, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 22, 2026EX1GSOU EXTENSION 1 GRANTED—
Jan 21, 2026EXT1SOU EXTENSION 1 FILED—
Jan 21, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 22, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 27, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 27, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 21, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 24, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 22, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 22, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 19, 2025RGRRREINSTATEMENT GRANTED - RESPONSE RECEIVED—
Mar 19, 2025PCGRPETITION TO DIRECTOR GRANTED—
Mar 11, 2025APETASSIGNED TO PETITION STAFF—
Nov 24, 2024TPDRTEAS PETITION TO DIRECTOR RECEIVED—
Nov 5, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 5, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 16, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 25, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 25, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Sep 25, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 25, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 25, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 11, 2024GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jun 11, 2024GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 11, 2024CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 8, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 8, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 8, 2023ALIEASSIGNED TO LIE—
Jun 6, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 6, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 6, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 6, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 2, 2023DOCKASSIGNED TO EXAMINER—
May 19, 2022MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
May 18, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 17, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance